DRTS Alpha Tau Medical Ltd.
$14.43▼ -0.07%
Healthcare
Other
After hours
$14.68▲ +1.73%
Sep 11, 7:30 PM ET
Volume 405.3K
Avg Volume (10D) 771.2K
Key Metrics & Fundamentals
Market Cap
$1.33B
P/E Ratio
–
Div Yield
–%
52W Range
3.43 - 15.17
% vs 50 MA
6.81%
% vs 200 MA
60.33%
RSI-14
54.1
MACD Histogram
-0.1000
Beta (1Y vs SPY)
2.12
Gross Rev
$0
Gross Profit
$0
EBITDA
-$55.05M
COGS
–
Operating Exp
$13.78M
Operating Income
-$13.78M
EBIT
-$13.78M
Pretax Income
-$45.58M
Net Income
-$45.81M
Price & Volume History
Loading chart…
Recent News
Alpha Tau to Participate in September Investor Conferences
GlobeNewswire · Sep 2, 2026 12:00 PM
Alpha Tau Medical Completes Patient Enrollment in Pancreatic Cancer Study
MT Newswires · Aug 31, 2026 12:29 PM
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
GlobeNewswire · Aug 31, 2026 12:00 PM
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
Zacks Small Cap Research · Aug 28, 2026 9:30 AM
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
GlobeNewswire · Aug 17, 2026 12:00 PM
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 10, 2026 8:01 PM
Alpha Tau Medical Files for Dual Listing on Tel Aviv Stock Exchange
MT Newswires · Aug 10, 2026 1:25 PM
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial
Simply Wall St. · Aug 1, 2026 6:16 AM
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success
GlobeNewswire · Jul 21, 2026 12:30 PM
Alpha Tau Medical Treats First Immunocompromised Patient in Alpha DaRT Study
MT Newswires · Jul 15, 2026 1:48 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See DRTS's money flow as a full page
Social Sentiment
Avg +0.70 · 21 posts
DiscussionNewsCurious if anyone has thoughts about DRTS (Alpha Tau Medical).
r/stocks · Aug 7, 2026
The post expresses interest and optimism about DRTS, seeking opinions on both the bullish and bearish cases.
positive
+0.60
NewsDiscussion“There may be a miracle working in my husband’s head right now as he sleeps beside me”: Amazing DRTS patient testimony from GBM trial!
r/stocks · Jul 15, 2026
The testimony is described as ‘amazing’ and ‘hopeful’, indicating a positive sentiment towards the company’s trial.
positive
+0.80
DiscussionTradeSaving Millions and Making Millions, now more than ever
r/stocks · May 21, 2026
User suspects stock pumping and potential 'rug pull', expressing concern for others' investments.
negative
+0.60
NewsDiscussionDRTS | Breakthrough In Glioblastoma Treatment
r/stocks · May 18, 2026
The sentiment is hopeful regarding the treatment's progress and the company's potential, despite acknowledging it's not a cure.
positive
+0.60
NewsDiscussionFollow up: Alpha Tau Medical DRTS (Huge win vs. rGBM)
r/stocks · May 13, 2026
The post highlights a 'huge win' and 'groundbreaking achievements' related to the DRTS trial, indicating strong optimism.
very_positive
+0.90
Page 1 of 5 (21 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.